Panel Session Title: Alzheimer Disease Panel
Date and Time: Wednesday May 26th, 11:00 a.m. Eastern time (8:00 a.m. Pacific time)
Presented by: Maxim Group LLC | Hosted by: M-Vest
Moderated by: Dr. Jason McCarthy
About INmune Bio, Inc.
INmune Bio, Inc. is a publicly traded (NASDAQ: INMB), clinical-stage biotechnology company focused on developing treatments that target the innate immune system to fight disease. INmune Bio has two product platforms. The DN-TNF product platform utilizes dominant-negative technology to selectively neutralize soluble TNF, a key driver of innate immune dysfunction and mechanistic target of many diseases. DN-TNF is currently being developed for COVID-19 complications (Quellor™), cancer (INB03™), Alzheimer’s and Treatment Resistant Depression (XPro1595), and NASH (LIVNate™). The Natural Killer Cell Priming Platform includes INKmune™ aimed at priming the patient’s NK cells to eliminate minimal residual disease in patients with cancer. IN
Europe Psychedelic Drugs Market Size, Share, Industry Growth Analysis, Segmentation Overview and For
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
Rapidly-Acting Treatments for Treatment-Resistant Depression (RAPID)
Rapidly-Acting Treatments for Treatment-Resistant Depression (RAPID) is an NIMH-funded research project that promotes development of speedier therapies for severe, treatment-resistant depression. The initiative is supporting a team of researchers, led by Maurizio Fava, M.D., of Massachusetts General Hospital, who are identifying and testing promising pharmacological and/or non-pharmacological treatments that lift depression within a few days.
By contrast, current antidepressant medications usually take a few weeks to work – and half of patients fail to fully respond. While a proven brain stimulation technique, electroconvulsive therapy (ECT), works faster, it runs a risk of cognitive side-effects and requires anesthesia and a surgical setting. The urgent need for improved, faster acting antidepressant treatments is underscored by the fact that severe depression can be life-threatening, due to heightened risk of
vimarsana © 2020. All Rights Reserved.